Pegasus Mercantile Inc. (XTCYF)
- Previous Close
0.0250 - Open
0.0250 - Bid 0.0136 x --
- Ask 0.3171 x 40000
- Day's Range
0.0250 - 0.0250 - 52 Week Range
0.0180 - 0.9980 - Volume
500,000 - Avg. Volume
0 - Market Cap (intraday)
835,193 - Beta (5Y Monthly) -0.37
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0200 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Pegasus Mercantile Inc. is an incubator, venture capital and accelerator firm specializing in incubation and startup. The firm seeks to invest in the public and private sectors that focus on preventative health, wellness issues, related consumer products, biotechnology, specific areas of pain, Psychedelic, depression, mental illness health and medicine sectors. By investing in pioneering techniques such as micro-dosing using organic compounds and synthetic molecules, we are focussing on ground breaking research with the aim of providing superior wellness benefits with less side effects, better for peoples and the planet. The firm seeks to invest in Canada. The firm also provides debt financing facility. Pegasus Mercantile Inc. was incorporated in 1998 and is headquartered in Vancouver, Canada with an additional office in Vancouver, Canada.
xtacytherapeutics.com--
Full Time Employees
September 30
Fiscal Year Ends
Sector
Industry
Recent News: XTCYF
View MorePerformance Overview: XTCYF
Trailing total returns as of 5/22/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: XTCYF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: XTCYF
View MoreValuation Measures
Market Cap
1.67M
Enterprise Value
1.69M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.52
Price/Book (mrq)
--
Enterprise Value/Revenue
15.62
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-77.28%
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-372.39k
Diluted EPS (ttm)
-0.0200
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-545.96k